KDM1A and cancer: Genetic depletion or pharmacological inhibition of LSD1 potently inhibits cell proliferation, cell migration, epithelial-to-mesenchymal transition (EMT), and chemoresistance, ultimately restraining cancer growth and metastasis [11, 12].